The breast tumors of Asian, Black and white patients have very different cellular, microbial, and genomic features that could potentially be used to personalize care or predict disease progression, according to research by investigators at the Johns Hopkins Kimmel Cancer Center.
Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center researchers showed in a new study.
